Delivery Order SPE2DB22D2211-SPE2DB25FRYWH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,357.45 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S on September 12, 2025, with a ceiling value of $1,414.08 and an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,536.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain relief medication. The contract, awarded on October 31, 2025, is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,542.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain relief medication. The contract is a firm fixed price delivery order with no set-aside designation, issued competitively on October 24, 2025, with an ultimate completion date of October 27, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,834.22 and firm fixed pricing. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $5,301.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and was competitively awarded without any set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,418.56 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price delivery order carries a ceiling value of $12,698.20 and will be completed by September 25, 2025. The award utilized competitive procedures with no set-aside designation, demonstrating the contractor's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $4,158.32 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,772.64 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order is a...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRYWHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,551.14 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The contract, awarded on June 11, 2025, with an ultimate completion date of June 12, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary distribution center for federal medical procurement activities. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support across multiple therapeutic domains for military healthcare systems and other federal agencies. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contract awards demonstrating capability to fulfill diverse medical product requirements through open competition, supporting the Defense Health Agency, U.S. Coast Guard, and related government healthcare organizations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/11/25 |